Enhertu is a specifically engineered HER2-directed antibody drug conjugate (ADC) being jointly developed and commercialised by AstraZeneca and Daiichi Sankyo.

from mint - Science https://ift.tt/fuAKT7w
https://ift.tt/ciUbzLR

Post a Comment

Previous Post Next Post